Neustrup Malene Aaby, Ottenhoff Tom H M, Jiskoot Wim, Bouwstra Joke A, van der Maaden Koen
Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Pharm Res. 2024 Dec;41(12):2347-2361. doi: 10.1007/s11095-024-03792-1. Epub 2024 Nov 27.
Microfluidics has emerged as a promising technique to prepare nanoparticles. However, the current microfluidic devices are mainly chip-based and are often integrated into expensive systems that lack on-the-spot versatility. The aim of this study was to set up a modular microfluidic system based on low-cost capillaries and reusable, easy-to-clean building blocks that can prepare poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles with and without incorporated water-soluble biomacromolecules.
A two-syringe system variant of the microfluidic system was set up to prepare PLGA particles and to investigate how the flow rates, solvents, and PLGA concentrations impacted the PLGA nanoparticle formation. A three-syringe system was designed to examine the incorporation of proteins into the PLGA particles.
The formation of the nanoparticles was affected by the PLGA concentration in the organic solvent, where an increasing concentration led to larger particle diameters (33-180 nm), and by the total flow rate, where an increase in the total flow rate led to smaller nanoparticles (197-77 nm). Using ultrapure water as the aqueous solvent resulted in precipitation at the outlet at higher PLGA concentrations. Aqueous poly(vinyl alcohol) created neutral particles in contrast to the negatively charged particles obtained with ultrapure water or an ethanol-water mixture. Incorporation of the proteins ovalbumin or lysozyme with a three-syringe system resulted in encapsulation efficiencies above 40%.
A cheap and easily adjustable modular microfluidic system was developed to prepare PLGA nanoparticles with highly reproducible particle diameters that can effectively be loaded with proteins for drug and vaccine delivery.
微流控技术已成为制备纳米颗粒的一种有前景的技术。然而,当前的微流控装置主要基于芯片,并且常常集成到缺乏现场通用性的昂贵系统中。本研究的目的是建立一种基于低成本毛细管和可重复使用、易于清洁的组件的模块化微流控系统,该系统能够制备含有和不含水溶性生物大分子的聚(D,L-乳酸-乙醇酸共聚物)(PLGA)纳米颗粒。
建立微流控系统的双注射器系统变体以制备PLGA颗粒,并研究流速、溶剂和PLGA浓度如何影响PLGA纳米颗粒的形成。设计了三注射器系统以检查蛋白质掺入PLGA颗粒的情况。
纳米颗粒的形成受有机溶剂中PLGA浓度的影响,浓度增加导致粒径增大(33 - 180 nm),还受总流速的影响,总流速增加导致纳米颗粒变小(197 - 77 nm)。使用超纯水作为水性溶剂在较高PLGA浓度下会在出口处产生沉淀。与用超纯水或乙醇 - 水混合物获得的带负电颗粒相比,水性聚乙烯醇产生中性颗粒。使用三注射器系统掺入蛋白质卵清蛋白或溶菌酶导致包封效率高于40%。
开发了一种廉价且易于调节的模块化微流控系统,用于制备具有高度可重复粒径的PLGA纳米颗粒,该纳米颗粒可有效地负载蛋白质用于药物和疫苗递送。